NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Aeolus Pharmaceuticals, Inc.



Aeolus Pharmaceuticals Completes $1.5 Million Financing



April 17th, 2009

Aeolus Pharmaceuticals, Inc. (OTC Bulletin Board: AOLS) announced that it completed a $1.5 million financing with two existing institutional shareholders, both of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing agreement, Aeolus received $1.5 million in gross proceeds in exchange for 5,357,143 shares of Aeolus Pharmaceuticals common stock, and 5 year warrants to purchase up to 13,392,857 additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.35 per share. The proceeds from the transaction will be used to fund animal efficacy studies in Acute Radiation Syndrome, manufacturing of drug substance and for general...


Source: Health Business Week (2009-04-17)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login